Market Tracker

01/19 4:39pm ET

NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

3.65
Delayed Data
As of Jan 19
 +0.05 / +1.39%
Today’s Change
1.77
Today|||52-Week Range
5.29
+10.61%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close3.60
Today’s open3.60
Day’s range3.55 - 3.65
Volume12,214
Average volume (3 months)42,260
Market cap$54.5M
Dividend yield--
Data as of 3:59pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)+72.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+315.65%
P/E ratioNM
Price/Sales1.28
Price/Book--

Competitors

----
AVIRAviragen Therapeutic...-0.10-7.20%
AMPEAmpio Pharmaceutical...-0.01-0.99%
MEIPMEI Pharma Inc+0.02+1.31%
Data as of 4:02pm ET, 01/19/2017

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$4.4M
Annual profit (last year)-$19.0M
Net profit margin-433.07%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer, Secretary &
Treasurer
Tom Paulson
Corporate headquarters
Emeryville, California

Forecasts